Production of an Additional 1. 4M Doses of REGEN-COV

Award Notice Posted

Solicitation number
W15QKN-21-C-0014
Agency
Awarded
to Regeneron Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
W15QKN-21-C-0014 Federal contract award
Place of performance
Tarrytown, New York 10591, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground published this Award Notice for the production of an additional 1.4 million doses of REGEN-COV (casirivimab and imdevimab) in support of the national emergency response to COVID-19. The notice advises that contract W15QKN-21-C-0014 was awarded to Regeneron Pharmaceuticals, Inc. on September 14, 2021 for $2.94 billion to produce the additional 1.4 million doses of the antibody therapeutic.

Notice text

Production of an Additional 1.4M Doses of REGEN-COV (casirivimab and imdevimab) in Support of National Emergency Response to Coronavirus 2019 (COVID-19).  This is a sole source action under the authority of 10 United States Code (U.S.C.) 2304 (c)(2), as implemented by Federal Acquisition Regulation (FAR) 6.302-2 -- Unusual and Compelling Urgency.

Awarded contract W15QKN-21-C-0014 to Regeneron Pharmaceuticals, Inc. for 2940000000.00 on 2021-09-14.

Files

File Type Posted
JA 9-28-2021 Redacted.pdf PDF

Notice history

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors